LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.625
-0.005 (-0.31%)
Oct 31, 2025, 4:00 PM EDT - Market closed

LAVA Therapeutics Revenue

LAVA Therapeutics had revenue of $4.99M in the twelve months ending June 30, 2025, down -32.55% year-over-year. In the year 2024, LAVA Therapeutics had annual revenue of $11.98M with 77.01% growth.

Revenue (ttm)
$4.99M
Revenue Growth
-32.55%
P/S Ratio
8.75
Revenue / Employee
$146,765
Employees
34
Market Cap
42.75M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202411.98M5.21M77.01%
Dec 31, 20236.77M-12.62M-65.09%
Dec 31, 202219.39M14.04M262.45%
Dec 31, 20215.35M1.60M42.78%
Dec 31, 20203.75M--
Jan 1, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
Eli Lilly and Company59.42B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG56.37B
Novo Nordisk49.11B
Revenue Rankings